Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin Patch in HIV-Associated Neuropathy
NCT00061152Phase 2Unknown
- Sponsor
- NeurogesX
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of capsaicin 8% patch in HIV-associated neuropathy, sponsored by NeurogesX. Primary endpoints: Tolerability of high-concentration capsaicin patches and Safety of high-concentration capsaicin patches. Status: unknown.
02
Drugs
capsaicin 8% patch
03
Conditions
HIV-associated neuropathy
Beyond the preview
Go deeper on NCT00061152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061152.